Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tilapia | 1 | 2017 | 1 | 0.600 |
Why?
|
| 1-Butanol | 1 | 2017 | 1 | 0.600 |
Why?
|
| Porins | 1 | 2017 | 2 | 0.600 |
Why?
|
| Metallothionein | 1 | 2017 | 4 | 0.590 |
Why?
|
| Clostridium | 1 | 2017 | 6 | 0.590 |
Why?
|
| Escherichia coli | 1 | 2017 | 83 | 0.570 |
Why?
|
| Drug Implants | 1 | 2016 | 10 | 0.550 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2016 | 5 | 0.550 |
Why?
|
| Doxorubicin | 1 | 2016 | 60 | 0.540 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 548 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 252 | 0.350 |
Why?
|
| Gene Expression Profiling | 6 | 2017 | 321 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 78 | 0.300 |
Why?
|
| Apoptosis | 3 | 2017 | 352 | 0.290 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 159 | 0.280 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 692 | 0.270 |
Why?
|
| Mitochondria | 2 | 2017 | 181 | 0.260 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 389 | 0.250 |
Why?
|
| Signal Transduction | 6 | 2017 | 674 | 0.230 |
Why?
|
| Rhabdoid Tumor | 2 | 2014 | 4 | 0.210 |
Why?
|
| Teratoma | 2 | 2014 | 12 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 114 | 0.210 |
Why?
|
| Animals | 7 | 2017 | 7339 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2015 | 174 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2017 | 14 | 0.180 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 35 | 0.170 |
Why?
|
| Mice, Nude | 2 | 2017 | 277 | 0.160 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2009 | 11 | 0.160 |
Why?
|
| Protein-Serine-Threonine Kinases | 2 | 2009 | 44 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 58 | 0.150 |
Why?
|
| Naphthoquinones | 1 | 2017 | 3 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 302 | 0.150 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 1 | 0.150 |
Why?
|
| Plant Lectins | 1 | 2017 | 2 | 0.150 |
Why?
|
| Genetic Enhancement | 1 | 2017 | 5 | 0.150 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2017 | 9 | 0.150 |
Why?
|
| Protein Engineering | 1 | 2017 | 17 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 38 | 0.150 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Histones | 1 | 2017 | 49 | 0.140 |
Why?
|
| Cell Membrane | 1 | 2017 | 98 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 588 | 0.140 |
Why?
|
| Calcium Chloride | 1 | 2016 | 3 | 0.140 |
Why?
|
| Catalase | 1 | 2016 | 16 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 95 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 63 | 0.140 |
Why?
|
| Peroxides | 1 | 2016 | 31 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 44 | 0.140 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 6 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2015 | 35 | 0.130 |
Why?
|
| Dermatomyositis | 1 | 2015 | 19 | 0.130 |
Why?
|
| Factor VII | 1 | 2015 | 5 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 13 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2015 | 8 | 0.130 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 17 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 92 | 0.130 |
Why?
|
| Fibrinogen | 1 | 2015 | 42 | 0.130 |
Why?
|
| Factor VIII | 1 | 2015 | 22 | 0.130 |
Why?
|
| Oxygen | 1 | 2016 | 139 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 101 | 0.130 |
Why?
|
| RNA | 1 | 2015 | 89 | 0.130 |
Why?
|
| Humans | 15 | 2017 | 29553 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 174 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 484 | 0.110 |
Why?
|
| Nephroma, Mesoblastic | 1 | 2012 | 1 | 0.110 |
Why?
|
| Receptor, trkC | 1 | 2012 | 1 | 0.110 |
Why?
|
| Survivors | 1 | 2014 | 149 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 337 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 192 | 0.090 |
Why?
|
| Neoplasms | 1 | 2015 | 628 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 6 | 0.080 |
Why?
|
| Mice | 4 | 2017 | 2387 | 0.070 |
Why?
|
| Lysine | 2 | 2017 | 24 | 0.070 |
Why?
|
| Cell Survival | 2 | 2017 | 278 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 208 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 520 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2015 | 523 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2015 | 251 | 0.060 |
Why?
|
| Peptide Initiation Factors | 1 | 2003 | 2 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2015 | 861 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2003 | 68 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 933 | 0.050 |
Why?
|
| Male | 6 | 2017 | 18012 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 576 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 984 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 475 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2017 | 12 | 0.040 |
Why?
|
| Caspases | 1 | 2017 | 42 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2017 | 4 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 13 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2017 | 72 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 37 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2016 | 3 | 0.040 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 4 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 73 | 0.040 |
Why?
|
| Cytosol | 1 | 2016 | 26 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 121 | 0.040 |
Why?
|
| Protein Transport | 1 | 2016 | 75 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 76 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2016 | 67 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 155 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 101 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 105 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 40 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 165 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 109 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 334 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 26 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 302 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2015 | 20 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 90 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 68 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 225 | 0.030 |
Why?
|
| Female | 4 | 2015 | 18379 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 143 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 375 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 185 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 225 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 148 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 243 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 441 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 633 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 355 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2012 | 1 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 11 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2012 | 2 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 38 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 16 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 864 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2012 | 53 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 1172 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 1080 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1701 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 13 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1225 | 0.020 |
Why?
|
| Child | 1 | 2015 | 2233 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 251 | 0.020 |
Why?
|
| Inbreeding | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 9 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2009 | 7 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 143 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2009 | 11 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2009 | 34 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 49 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2009 | 174 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 66 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 83 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 43 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 36 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 130 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2009 | 605 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 425 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 3764 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 189 | 0.020 |
Why?
|
| Cell Movement | 1 | 2008 | 161 | 0.020 |
Why?
|
| Infant | 1 | 2009 | 976 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 713 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3284 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 12 | 0.010 |
Why?
|
| Genes, ras | 1 | 2003 | 27 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 97 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 47 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2003 | 69 | 0.010 |
Why?
|
| Proteomics | 1 | 2003 | 92 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 9590 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 286 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 225 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 10936 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 797 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 438 | 0.010 |
Why?
|